ATX levels in severe COVID-19 patients correlated with the increased IL-6 serum levels (61), as recently also shown in ARDS (62), as well in acute-on-chronic liver failure (ACLF) patients (73), suggesting interdependent regulation of expression. This evidence concerns the gene IL6 and COVID-19.